What Matters: realizing value for innovation

Overcoming hurdles to market access is no small matter. Increasingly, cost-effectiveness and cost-containment are trumping safety and efficacy. What Matters is the place to examine and address the challenges facing biopharma in gaining market access.

If your passion is realizing value for innovation, welcome to the conversation.